Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
107,767 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
686,225 views
1 reaction
Last Post ECO
by ECO
 
Started by ltd50, 11-16-2012, 11:14 AM
0 responses
1,730 views
0 reactions
Last Post ltd50
by ltd50
 
Started by vebaev, 11-16-2012, 03:02 AM
2 responses
2,015 views
0 reactions
Last Post vebaev
by vebaev
 
Started by tahamasoodi, 11-13-2012, 06:44 AM
4 responses
1,547 views
0 reactions
Last Post westerman  
Started by sunfuhui, 09-05-2012, 03:06 PM
20 responses
7,642 views
0 reactions
Last Post westerman  
Started by masylichu, 11-16-2012, 12:45 AM
2 responses
4,204 views
0 reactions
Last Post masylichu  
Started by yvan.wenger, 11-16-2012, 03:53 AM
0 responses
2,036 views
0 reactions
Last Post yvan.wenger  
Started by miroslav, 11-05-2012, 06:11 AM
2 responses
3,228 views
0 reactions
Last Post miroslav  
Started by rnathg, 11-16-2012, 01:40 AM
0 responses
1,867 views
0 reactions
Last Post rnathg
by rnathg
 
Started by Josim, 04-26-2012, 12:53 AM
0 responses
4,830 views
0 reactions
Last Post stephwen  
Started by jjk, 11-15-2012, 11:37 PM
0 responses
2,313 views
0 reactions
Last Post jjk
by jjk
 
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    Yesterday, 05:41 AM
  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 12:32 PM
0 responses
5 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-24-2026, 10:32 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-20-2026, 11:17 AM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Working...